Due to current HHS restructuring, the information provided on aspe.hhs.gov is not being updated currently. Please refer to hhs.gov for more information.
An official website of the United States government
Here’s how you know
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Congress has directed HHS to operate the Children’s Interagency Coordinating Council (CICC). The CICC is charged with fostering greater coordination and transparency on child policy across federal agencies and examining a broad array of cross-cutting issues affecting child poverty and child well-being.
Prescription drug prices are a top concern for policymakers and the public, but little data is available on prescription drug prices or other costs that contribute to premiums for commercial drug coverage.
This report presents findings of an environmental scan and semi-structured interviews with key contributors, including governmental and non-governmental contributors, such as researchers, clinicians, advocates, service provider/payers, and policy experts. The findings included in this report are organized by specific domains and themes found within the peer-reviewed and grey literature.
Cardiovascular disease (CVD) is a broad category of diseases affecting approximately half of American adults. Despite progress in treatment and management, CVD still has a large health, mortality, and economic burden. This report to Congress describes CVD and its adverse health outcomes, as well as certain risk factors and prevention and treatment options.
This report has been prepared by the Office of the Assistant Secretary for Health (OASH), Office on Women's Health (OWH) and the Assistant Secretary for Planning and Evaluation (ASPE) in concert with other HHS agencies within the U.S. Department of Health and Human Services (HHS). This report discusses activities and outcomes of HHS programs addressing the maternal health crisis.
The Welfare Indicators Act of 1994 (Public Law 103-432) requires the Secretary of the Department of Health and Human Services to prepare an annual report to Congress on indicators and predictors of “welfare dependence.” That Act requires the report to include three programs: Temporary Assistance for Needy Families (TANF) program (which replaced the Aid to Families with Dependent Children (AFDC)
As part of the Consolidated Appropriations Act, 2023, Congress provided HHS with funding for the Children’s Interagency Coordinating Council (CICC). The CICC is charged with fostering greater coordination and transparency on child policy across federal agencies and examining a broad array of cross-cutting issues affecting child poverty and child well-being.
Prescription drug shortages are an ongoing concern in the United States (U.S.). While prior analyses explore the frequency of drug shortages in the U.S., little is known about the extent to which U.S. shortages impact consumer costs and healthcare systems. Drug shortages impact consumer costs in various ways.